Building on preclinical work (Hong X, Adv Sci, 2023) demonstrating the antitumor activity of disitamab vedotin (RC48) in HER2-expressing orthotopic bladder cancer models, Dr. Chen and colleagues ...

Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change ...

Invikafusp alfa, a dual T-cell agonist targeting subsets of tumor-infiltrating lymphocytes, can elicit responses in patients with heavily pretreated gastrointestinal cancers, according to research ...

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

In esophageal and stomach cancers ... have too much of a protein called human epidermal growth factor receptor 2 (HER2). People with HER2-positive cancer can benefit from a HER2-directed medication ...

Preliminary results of an observational clinical trial underway at Roswell Park Comprehensive Cancer Center are shedding light on why some patients with an aggressive form of metastatic breast cancer ...

Objective: The risk prediction model is an effective tool for risk stratification and is expected to play an important role in the early detection and prevention of esophageal cancer. This study ...

Esophageal cancer, illustration. Barrett’s esophagus affects the lining of the esophagus and increases the risk of developing esophageal adenocarcinoma, a serious and often deadly cancer.

Fellow comic book writer Mark Waid revealed on Facebook that Shooter lost his fight with esophageal cancer, something he had “been battling for some time.” Despite being a controversial figure, ...

Kim Kardashian Confirms Her "Lifer" Friend Lindsay May Died After Cancer Battle Kim Kardashian mourned the death of Lindsay May, a member of her "lifers" group of childhood friends: "I felt this ...

Capt. Brandon Minneman, 43, a 17-year veteran of Kent-based Puget Sound Fire, died June 24 of cancer. “It is with deep sadness that we announce the passing of Capt. Brandon Minneman to cancer,” ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists. Patients need to rely on ...